Fresenius Kabi Introduces Bortezomib for Injection

World News: . []

Fresenius Kabi announced today the availability in the United States of Bortezomib for Injection Fresenius Kabi Bortezomib for Injection is available as a single dose vial containing 35 mg of lyophilized powder This press releas...

More news and information about Fresenius Kabi

Published By:

Business Wire: 15:00 GMT Friday 12th January 2018

Published: .

Search for other references to "fresenius" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers